DIHYDROOROTATE DEHYDROGENASE IS A HIGH-AFFINITY BINDING-PROTEIN FOR A77-1726 AND MEDIATOR OF A RANGE OF BIOLOGICAL EFFECTS OF THE IMMUNOMODULATORY COMPOUND
Ra. Williamson et al., DIHYDROOROTATE DEHYDROGENASE IS A HIGH-AFFINITY BINDING-PROTEIN FOR A77-1726 AND MEDIATOR OF A RANGE OF BIOLOGICAL EFFECTS OF THE IMMUNOMODULATORY COMPOUND, The Journal of biological chemistry, 270(38), 1995, pp. 22467-22472
A protein with high affinity (K-d 12 nM) for the immunomodulatory comp
ound A77 1726 has been isolated from mouse spleen and identified as th
e mitochondrial enzyme dihydroorotate dehydrogenase (EC 1.3.3.1), The
purified protein had a pi 9.6-9.8 and a subunit M(r) of 43,000, Peptid
es derived from the mouse protein displayed high microsequence similar
ity to human and rat dihydroorotate dehydrogenase with, respectively,
35 and 39 out of 43 identified amino acids identical. Dihydroorotate d
ehydrogenase catalyzes the fourth step in de novo pyrimidine biosynthe
sis. The in vitro antiproliferative effects of A77 1726 are mediated b
y enzyme inhibition and can be overcome by addition of exogenous uridi
ne, The rank order of potency of A77 1726 and its analogues in binding
or enzyme inhibition was similar to that for inhibition of the mouse
delayed type hypersensitivity response. It is proposed that inhibition
of dihydroorotate dehydrogenase is an in vivo mechanism of action of
the A77 1726 class of compounds. This was confirmed using uridine to c
ounteract inhibition of the murine acute graft versus host response.